[EN] BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS AND METHODS OF USE THEREOF<br/>[FR] DÉRIVÉS D'ACIDE BILIAIRE UTILISÉS COMME AGONISTES DE FXR/TGR5 ET LEURS PROCÉDÉS D'UTILISATION
申请人:ENANTA PHARM INC
公开号:WO2016086134A1
公开(公告)日:2016-06-02
The present invention provides compounds of amino-substituted bile acid compounds, pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions. In another embodiment, the present invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound or combination of compounds of the present invention, or a pharmaceutically acceptable salt form, stereoisomer, solvate, hydrate or combination thereof, in combination with a pharmaceutically acceptable carrier or excipient.